MedTrace Logo

Adoptive Cellular Therapy and Radiation Therapy After Surgery in Treating Patients With Esophageal Cancer

NCT01691664 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2019-11-04

No results posted yet for this study

Summary

Cytokine-induced killer (CIK) cells show cytolytic activity against tumor. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining Radiation therapy with adoptive cellular therapy after surgery may be more effective than uses radiation therapy alone in treating esophageal cancer.

Conditions

  • Esophageal Cancer

Interventions

RADIATION

Only radiation therapy

Patients only radiation therapy after surgery

OTHER

Radiation therapy plus DC-CIK cellular therapy

Patients receive radiation therapy plus DC-CIK cellular therapy after surgery

Sponsors & Collaborators

  • Capital Medical University

    lead OTHER

Principal Investigators

  • Jun Ren, MD, PhD · Capital Medical University Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2021-12-31
Completion
2022-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01691664 on ClinicalTrials.gov